Literature DB >> 1191567

Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets.

P N Walsh, D C Mills, F I Pareti, G J Stewart, D E Macfarlane, M M Johnson, J J Egan.   

Abstract

The platelets from two related patients with the hereditary giant platelet syndrome were examined. They were larger than normal but otherwise ultrastructurally normal; they contained increased storage pools of adenine nucleotides and heparin-neutralizing activity and took up serotonin at an increased rate. They aggregated normally with ADP and collagen but failed to aggregate with bovine factor VIII and Ristocetin. Some change in shape occurred with ADP, and the reduction in adenylate energy change after addition of ADP to platelet-rich plasma was smaller than normal. Platelet coagulant activities including contact product forming activity, intrinsic factor-Xa forming activity and platelet factor 3 activity were normal or increased, but collagen-induced coagulant activity was absent whether tested in washed platelet suspensions or platelet-rich plasma. Platelet washing experiments showed decreased binding of factors V and VIII to hereditary giant platelets and no detectable factor XI in washed platelet suspensions. It is concluded that (1) the hereditary giant platelets studied lacked a binding mechanism for factors, V, VIII and XI; (2) the normal development of collagen-induced coagulant activity apparently depends upon the binding of factor XI to the platelet membrane; and (3) the defective prothrombin consumption observed in these patients may have resulted from the failure of their platelets to bind factor XI.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1191567     DOI: 10.1111/j.1365-2141.1975.tb02750.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

1.  Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.

Authors:  C S Jenkins; D R Phillips; K J Clemetson; D Meyer; M J Larrieu; E F Lüscher
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

2.  Evidence that a 210,000-molecular-weight glycoprotein (GP 210) serves as a platelet Fc receptor.

Authors:  R B Stricker; P T Reyes; L Corash; M A Shuman
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

3.  The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.

Authors:  B S Coller
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

4.  [Enzyme activities in normal platelets of different specific gravity (author's transl)].

Authors:  O Nerke; H C Benöhr; U Thorau; H D Waller
Journal:  Klin Wochenschr       Date:  1977-01-15

5.  Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.

Authors:  L F Brass; S J Shattil
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

6.  Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.

Authors:  H J Weiss; V T Turitto; H R Baumgartner
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

7.  8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Authors:  Joanna Lecka; Irina Gillerman; Michel Fausther; Mabrouka Salem; Mercedes N Munkonda; Jean-Philippe Brosseau; Christine Cadot; Mireia Martín-Satué; Pedro d'Orléans-Juste; Eric Rousseau; Donald Poirier; Beat Künzli; Bilha Fischer; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  The interaction of bovine factor VIII with human platelets.

Authors:  E P Kirby; D C Mills
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

9.  Reduced thrombin binding and aggregation in Bernard-Soulier platelets.

Authors:  G A Jamieson; T Okumura
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

10.  Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI.

Authors:  M S Lipscomb; P N Walsh
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.